Bihua Chen - Feb 8, 2025 Form 4 Insider Report for Helix Acquisition Corp. II (HLXB)

Signature
/s/ Bihua Chen
Stock symbol
HLXB
Transactions as of
Feb 8, 2025
Transactions value $
$0
Form type
4
Date filed
2/10/2025, 05:06 PM
Previous filing
Jun 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLXB Class B Ordinary Shares Other $0 -30K -0.67% $0.00 4.48M Feb 8, 2025 Class A Ordinary Shares 30K See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Class B ordinary shares will automatically convertible into Class A ordinary shares at the time of the Issuer's initial business combination on a one-for-one basis (unless otherwise provided in Issuer's initial business combination agreement), subject to adjustment for share subdivisions, share consolidations, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights as described under the heading "Description of Securities--Founder Shares and Private Placement Shares" in the Issuer's registration statement on Form S-1 (File No. 333-276591) and have no expiration date.
F2 On February 8, 2025, Helix Holdings II LLC (the "Sponsor") transferred 30,000 Class B Ordinary Shares owned by it to Albert A. Holman, III in connection with his appointment as a director of the Issuer.
F3 The Sponsor is the record holder of such securities. Cormorant Private Healthcare Fund III, LP, a Delaware limited partnership, Cormorant Private Healthcare Fund V, LP, a Delaware limited partnership, and Cormorant Global Healthcare Master Fund, LP, a Cayman Islands limited partnership, are the members of the Sponsor. Bihua Chen is the manager of the Sponsor and is the managing member of each of the three members of the Sponsor and has voting and investment discretion with respect to the ordinary shares held of record by the Sponsor. Ms. Chen disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.